Top Markets
Coin of the day
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Rang in Aktien #30680
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Aktienkurs
$0.91968646
Zuletzt synchronisiert: 2026-08-18
Marktkapitalisierung
$15.91M
Veränderung (1 Tag)
2.23%
Veränderung (1 Jahr)
-52.75%
Land
KR
Handel Xcell Therapeutics, Inc. (373110)

Kategorie

Dividendenrendite-Verlauf für Xcell Therapeutics, Inc. (373110)
Dividendenrendite (TTM) von Xcell Therapeutics, Inc. (Aktienkürzel: 373110) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Xcell Therapeutics, Inc. (373110) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE